Benzinga | Mar 4, 2021 07:08AM EST

Fulcrum Therapeutics Q4 EPS $(0.64) Up From $(0.71) YoY, Sales $4.22M Beat $1.31M Estimate

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.64) per share. This is a 9.86 percent increase over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $4.22 million which beat the analyst consensus estimate of $1.31 million by 222.52 percent.